Alembic Pharmaceuticals

quarterly
yearly
ParticularsDec '24Mar '25Jun '25Sep '25Dec '25
Revenue1,7021,7841,7171,9171,892
Expenses1,5251,5911,5271,6951,686
EBITDA269.72286.11287.85322.60309.00
EBIT200.04216.46213.63247.95184.81
Profit Before Tax177.78191.94190.11223.72161.50
Net Profit137.70156.63153.63183.71131.95
Financial Ratios
Operating Profit Margin15.96%16.13%16.80%16.96%14.12%
Net Profit Margin8.18%8.87%9.02%9.67%8.93%
Earning Per Share (Diluted)7.017.987.859.406.76
Dividends Per Share0.000.000.000.000.00